Literature DB >> 10189273

Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII.

L Kreilgaard1, L S Jones, T W Randolph, S Frokjaer, J M Flink, M C Manning, J F Carpenter.   

Abstract

Agitation- and freeze-thawing-induced aggregation of recombinant human factor XIII (rFXIII) is due to interfacial adsorption and denaturation at the air-liquid and ice-liquid interfaces. The aggregation pathway proceeds through soluble aggregates to formation of insoluble aggregates regardless of the denaturing stimuli. A nonionic surfactant, polyoxyethylene sorbitan monolaurate (Tween 20), greatly reduces the rate of formation of insoluble aggregates as a function of surfactant concentration, thereby stabilizing native rFXIII. Maximum protection occurs at concentrations close to the critical micelle concentration (cmc), independent of initial protein concentration. To study the mechanistic aspects of the surfactant-induced stabilization, a series of spectroscopic studies were conducted. Electron paramagnetic resonance spectroscopy indicates that binding is not occurring between Tween 20 and either the native state or a folding intermediate state of rFXIII. Further, circular dichroism spectroscopy suggests that Tween 20 does not prevent the secondary structural changes induced upon guanidinium hydrochloride-induced unfolding. Taken together, these results imply that Tween 20 protects rFXIII against freeze-thawing- and agitation-induced aggregation primarily by competing with stress-induced soluble aggregates for interfaces, inhibiting subsequent transition to insoluble aggregates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10189273     DOI: 10.1021/js980126i

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  45 in total

1.  Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations.

Authors:  Wei-Jie Fang; Wei Qi; John Kinzell; Steven Prestrelski; John F Carpenter
Journal:  Pharm Res       Date:  2012-07-06       Impact factor: 4.200

2.  Displacement of adsorbed insulin by Tween 80 monitored using total internal reflection fluorescence and ellipsometry.

Authors:  S H Mollmann; U Elofsson; J T Bukrinsky; S Frokjaer
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

Review 3.  Considerations for the Use of Polysorbates in Biopharmaceuticals.

Authors:  Michael T Jones; Hanns-Christian Mahler; Sandeep Yadav; Dilbir Bindra; Vincent Corvari; R Matthew Fesinmeyer; Kapil Gupta; Alexander M Harmon; Kenneth D Hinds; Atanas Koulov; Wei Liu; Kevin Maloney; John Wang; Ping Y Yeh; Satish K Singh
Journal:  Pharm Res       Date:  2018-05-24       Impact factor: 4.200

4.  Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties.

Authors:  Lynn E Macdonald; Karoline A Meagher; Matthew C Franklin; Natasha Levenkova; Johanna Hansen; Ashok T Badithe; Maggie Zhong; Pamela Krueger; Ashique Rafique; Naxin Tu; James Shevchuk; Saurabh Wadhwa; George Ehrlich; Joannie Bautista; Craig Grant; Lakeisha Esau; William T Poueymirou; Wojtek Auerbach; Lori Morton; Robert Babb; Gang Chen; Tammy Huang; Douglas MacDonald; Kenneth Graham; Cagan Gurer; Vera A Voronina; John R McWhirter; Chunguang Guo; George D Yancopoulos; Andrew J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-26       Impact factor: 11.205

5.  High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Authors:  Sébastien Dasnoy; Nancy Dezutter; Dominique Lemoine; Vivien Le Bras; Véronique Préat
Journal:  Pharm Res       Date:  2011-03-12       Impact factor: 4.200

6.  A new approach to explore the impact of freeze-thaw cycling on protein structure: hydrogen/deuterium exchange mass spectrometry (HX-MS).

Authors:  Aming Zhang; Wei Qi; Satish K Singh; Erik J Fernandez
Journal:  Pharm Res       Date:  2011-02-08       Impact factor: 4.200

Review 7.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

8.  Effect of formulation on the stability and aerosol performance of a nebulized antibody.

Authors:  Renaud Respaud; Denis Marchand; Christelle Parent; Thibaut Pelat; Philippe Thullier; Jean-François Tournamille; Marie-Claude Viaud-Massuard; Patrice Diot; Mustapha Si-Tahar; Laurent Vecellio; Nathalie Heuzé-Vourc'h
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

9.  The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study.

Authors:  Lu Liu; Wei Qi; Daniel K Schwartz; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2013-05-27       Impact factor: 3.534

10.  Effect of polysorbate 80 concentration on thermal and photostability of a monoclonal antibody.

Authors:  Meera Agarkhed; Courtney O'Dell; Ming-Ching Hsieh; Jingming Zhang; Joel Goldstein; Arvind Srivastava
Journal:  AAPS PharmSciTech       Date:  2012-11-14       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.